Tag Archives: TAX

Hot Heal Care Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-34294475&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/34294475/960×0.jpg?fit=scale&q; data-height=&q;638&q; data-width=&q;960&q;&g; The companies claim the&a;nbsp;merger will create one of the largest&a;nbsp;oil and gas companies&a;nbsp;focused on&a;nbsp;the&a;nbsp;Utica Shale in Appalachia. (Photographer: Ty Wright/Bloomberg)

Eclipse Resources Corp. has&a;nbsp;long been considered a takeover target.

&l;a href=&q;https://www.forbes.com/sites/clairepoole/2017/01/19/possible-oil-gas-takeover-targets-that-arent-in-the-permian-hot-spots/#6f4b93c1722a&q;&g;In January&l;/a&g;&a;nbsp;of last year, the natural gas producer in Appalachia was named as one of several potential oil and gas takeouts that&a;nbsp;wasn&s;t in the popular Permian Basin of Texas and New Mexico (one analyst said it could probably&a;nbsp;&l;span&g;accelerate activity on its&a;nbsp;own but was&a;nbsp;likely better off combining with another company). &l;/span&g;

Hot Heal Care Stocks To Invest In Right Now: Brunswick Corporation(BC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Brunswick Co. (NYSE:BC) have been given a consensus recommendation of “Buy” by the eighteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $71.33.

  • [By Ethan Ryder]

    Brunswick Co. (NYSE:BC) insider William Metzger sold 13,530 shares of the firm’s stock in a transaction that occurred on Tuesday, June 5th. The stock was sold at an average price of $67.42, for a total transaction of $912,192.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brunswick (BC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Brunswick (NYSE:BC) Q4 2018 Earnings Conference CallJan. 31, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Rich Duprey]

    Pontoon boats are a versatile vessel as they can be used for fishing, sports, cruising, and day trips. That latter part is key because rival boatmaker Brunswick (NYSE:BC) — which Polaris used to have a business relationship with when it was in the marine market — says that overnight trips with boats are fading. Industry site Boat Industry quotes Brunswick’s freshwater boat group President Jeff Kinsey as saying, “There’s been a clear shift toward day boating, and that speaks directly to the pontoon with its seating capacity, its open space, its amenities and its comfort.”

Hot Heal Care Stocks To Invest In Right Now: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Hot Heal Care Stocks To Invest In Right Now: Gentex Corporation(GNTX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Gentex (GNTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Gentex (NASDAQ:GNTX) and BorgWarner (NYSE:BWA) are both mid-cap auto/tires/trucks companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

  • [By Shane Hupp]

    Gentex (NASDAQ: GNTX) is one of 45 publicly-traded companies in the “Motor vehicle parts & accessories” industry, but how does it contrast to its competitors? We will compare Gentex to related companies based on the strength of its profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation.

  • [By Stephan Byrd]

    Gentex Co. (NASDAQ:GNTX) saw a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 13,914,567 shares, a growth of 19.4% from the July 31st total of 11,653,555 shares. Based on an average daily volume of 1,919,529 shares, the short-interest ratio is currently 7.2 days. Currently, 5.1% of the shares of the company are short sold.

  • [By Stephan Byrd]

    Delphi Technologies (NYSE: DLPH) and Gentex (NASDAQ:GNTX) are both mid-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Maxx Chatsko]

    The good news is that investors looking for opportunities in the future of transportation and renewables have more options than Tesla. Two stocks to consider: niche auto parts supplier Gentex (NASDAQ:GNTX) and well-positioned solar component supplier SolarEdge Technologies (NASDAQ:SEDG).

Hot Heal Care Stocks To Invest In Right Now: iShares Core S&P Total US Stock Mkt (ITOT)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Hundreds of exchange traded funds offer investors broad market exposure and many do so with nominal fees. Among the least expensive is the iShares Core S&P Total U.S. Stock Market ETF (NYSE: ITOT).

  • [By Shane Hupp]

    Traders purchased shares of iShares S&P 1500 Index Fund (BMV:ITOT) on weakness during trading hours on Wednesday. $50.39 million flowed into the stock on the tick-up and $29.44 million flowed out of the stock on the tick-down, for a money net flow of $20.95 million into the stock. Of all equities tracked, iShares S&P 1500 Index Fund had the 33rd highest net in-flow for the day. iShares S&P 1500 Index Fund traded down ($0.14) for the day and closed at $62.27

Best Safest Stocks To Invest In Right Now

As populist parties in Rome mobilize for an early election, Italian assets are once again being scrutinized for stresses that undermine the euro project.

The stakes are high. The anti-establishment politicians vying for leadership in the continent’s second-most indebted country want to boost spending in defiance of European Union budget strictures — and make battle with the entrenched order. As such, fears are growing that the fresh election would effectively constitute a referendum on whether the third-largest economy in the euro area should stay within in the single-currency bloc.

Here are five metrics to watch to gauge fear in the periphery and beyond:

#lazy-img-328110402:before{padding-top:56.25%;}

The best gauge of risk in any European bond market is a comparison with yields of Germany, the continent’s safest country to lend money to. Before the recent political flare-up, Italy was paying a premium of just over 1 percent compared to Germany to borrow in euros for 10 years. Now, that gap has more than doubled to 2.7 percent.

Best Safest Stocks To Invest In Right Now: Codexis, Inc.(CDXS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Codexis (NASDAQ:CDXS) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Monday.

  • [By Maxx Chatsko]

    Investors (and analysts) may use simple indicators, such as stock returns, to figure out where to invest their attention — and maybe even their hard-earned dollars. That would put two synthetic biology stocks on investors’ radars: Amyris (NASDAQ:AMRS) and Codexis (NASDAQ:CDXS), which have gained 155% and 140%, respectively, in the last year. Which one is the better buy?

  • [By Maxx Chatsko]

    Growth stocks can deliver most of your portfolio’s gains, and even make up for a few laggards. But they have a downside: One misstep can be all it takes for Wall Street to turn against them. That’s exactly what’s happened in 2018 to the world’s top lithium producer, Albemarle (NYSE:ALB), and the most reputable marijuana stock, Scotts Miracle-Gro (NYSE:SMG). That shouldn’t scare investors from buying high-growth companies, however. For instance, it looks as if tiny biotech Codexis (NASDAQ:CDXS) will grow into its premium valuation (and then some) sooner rather than later.

  • [By Timothy Green, Travis Hoium, and Maxx Chatsko]

    Three candidates are Match Group (NASDAQ:MTCH), Berkshire Hathaway (NYSE:BRK.B), and Codexis (NASDAQ:CDXS), according to three of our Motley Fool contributors. Here’s what you need to know about these promising stocks.

  • [By Shane Hupp]

    Citadel Advisors LLC bought a new position in shares of Codexis, Inc. (NASDAQ:CDXS) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,507 shares of the biotechnology company’s stock, valued at approximately $138,000.

  • [By Shane Hupp]

    Codexis (NASDAQ:CDXS) hit a new 52-week high and low during trading on Monday . The company traded as low as $14.45 and last traded at $13.98, with a volume of 520808 shares traded. The stock had previously closed at $13.50.

Best Safest Stocks To Invest In Right Now: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Best Safest Stocks To Invest In Right Now: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Best Safest Stocks To Invest In Right Now: KapStone Paper and Packaging Corporation(KS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KapStone Paper and Packaging (KS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Kapstone (KS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    These are some of the media headlines that may have impacted Accern Sentiment’s rankings:

    Get Kapstone alerts:

    Investor Interest Amplifies Stock EV For KapStone Paper and Packaging Corporation (NYSE:KS) (parkcitycaller.com) What is Clear choice Buy, Sell or Hold? KapStone Paper and Packaging Corporation (KS) (nysestocks.review) Is this stock is suitable for your portfolio? KapStone Paper and Packaging Corporation (KS) (stockquote.review) Investor Buzz: Earnings in Review for KapStone Paper and Packaging Corporation (NYSE:KS) (fisherbusinessnews.com) Kapstone (KS) vs. P H Glatfelter (GLT) Head-To-Head Survey (americanbankingnews.com)

    Several research analysts have issued reports on the company. Deutsche Bank cut Kapstone from a “buy” rating to a “hold” rating and set a $35.00 price target on the stock. in a report on Thursday, February 8th. ValuEngine raised Kapstone from a “hold” rating to a “buy” rating in a report on Thursday, February 8th. Zacks Investment Research raised Kapstone from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a report on Wednesday, January 31st. Citigroup reaffirmed a “neutral” rating and issued a $26.00 price target on shares of Kapstone in a report on Tuesday, January 30th. Finally, BMO Capital Markets cut Kapstone from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 30th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Kapstone currently has an average rating of “Hold” and an average target price of $32.17.

Best Safest Stocks To Invest In Right Now: LeMaitre Vascular, Inc.(LMAT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on LeMaitre Vascular (LMAT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    LeMaitre Vascular inc  (NASDAQ:LMAT)Q4 2018 Earnings Conference CallFeb. 19, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Shares of LeMaitre Vascular Inc (NASDAQ:LMAT) have been assigned an average rating of “Hold” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $34.40.

Best Safest Stocks To Invest In Right Now: CSG Systems International Inc.(CSGS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on CSG Systems International (CSGS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CSG International (CSGS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CSG International (NASDAQ:CSGS) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Saturday.

Top 10 Medical Stocks To Watch For 2019

Zacks Investment Research upgraded shares of UQM Technologies (NYSEAMERICAN:UQM) from a hold rating to a buy rating in a research note released on Saturday morning. They currently have $1.75 target price on the industrial goods maker’s stock.

According to Zacks, “UQM Technologies, Inc. is a developer and manufacturer of power dense, high efficiency electric motors, generators and power electronic controllers for the automotive, aerospace, medical, military and industrial markets. A major emphasis of the Company is developing products for the alternative energy technologies sector including propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles, under-the-hood power accessories and other vehicle auxiliaries and distributed power generation applications. The Company’s headquarters, engineering and product development center, and motor manufacturing operation are located in Frederick, Colorado. “

Top 10 Medical Stocks To Watch For 2019: CytomX Therapeutics, Inc.(CTMX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CytomX Therapeutics Inc (NASDAQ:CTMX) CEO Sean A. Mccarthy sold 2,028 shares of the company’s stock in a transaction on Tuesday, July 3rd. The shares were sold at an average price of $25.09, for a total transaction of $50,882.52. Following the completion of the sale, the chief executive officer now owns 84,091 shares of the company’s stock, valued at approximately $2,109,843.19. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    CytomX Therapeutics Inc. (NASDAQ: CTMX) is presenting on a couple different topics: probody conjugate (CX-2009) treatment in patients with advanced solid tumors and probody drug conjugate targeting CD166 in preclinical antitumor activity. Wedbush has an Outperform rating with a price target of $25, implying upside of 123% from Friday’s closing price of $11.22. The shares have a 52-week range of $10.91 to $35.00. The stock has a consensus price target of $29.20.

  • [By Shane Hupp]

    Shares of CytomX Therapeutics (NASDAQ:CTMX) have earned an average recommendation of “Buy” from the thirteen research firms that are currently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $39.86.

Top 10 Medical Stocks To Watch For 2019: Eaton Vance Enhanced Equity Income Fund II(EOS)

Advisors’ Opinion:

  • [By Shane Hupp]

    EOS (CURRENCY:EOS) traded up 9.3% against the US dollar during the 1 day period ending at 20:00 PM E.T. on July 2nd. During the last week, EOS has traded up 8.5% against the US dollar. One EOS token can now be purchased for $8.89 or 0.00135160 BTC on exchanges including Zebpay, CoinEx Market, ChaoEX and Tidex. EOS has a market cap of $7.96 billion and $1.02 billion worth of EOS was traded on exchanges in the last day.

  • [By Ethan Ryder]

    EOS (CURRENCY:EOS) traded 2.8% lower against the dollar during the 24-hour period ending at 23:00 PM E.T. on August 25th. In the last week, EOS has traded down 4% against the dollar. EOS has a total market capitalization of $4.43 billion and approximately $344.84 million worth of EOS was traded on exchanges in the last 24 hours. One EOS coin can now be bought for about $4.89 or 0.00073541 BTC on popular exchanges including Kucoin, Mercatox, ChaoEX and Bitfinex.

  • [By Joseph Griffin]

    EOS (CURRENCY:EOS) traded 0.7% higher against the U.S. dollar during the 1 day period ending at 16:00 PM ET on July 4th. In the last seven days, EOS has traded 13.1% higher against the U.S. dollar. One EOS token can now be purchased for approximately $9.05 or 0.00135304 BTC on major cryptocurrency exchanges including DragonEX, ChaoEX, Hotbit and HitBTC. EOS has a market cap of $8.11 billion and approximately $912.71 million worth of EOS was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    EOS (CURRENCY:EOS) traded 4.1% higher against the US dollar during the 24 hour period ending at 14:00 PM E.T. on June 27th. EOS has a total market capitalization of $7.24 billion and $772.07 million worth of EOS was traded on exchanges in the last 24 hours. Over the last week, EOS has traded down 22.9% against the US dollar. One EOS token can currently be purchased for approximately $8.08 or 0.00131687 BTC on major cryptocurrency exchanges including Kuna, Bibox, Cryptopia and CoinExchange.

Top 10 Medical Stocks To Watch For 2019: Codexis, Inc.(CDXS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Codexis (NASDAQ:CDXS) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Monday.

  • [By Keith Noonan, Daniel Miller, and Maxx Chatsko]

    Having even a few of these companies working in your favor over the long term can be a life-changing event. To help put readers on to some high-growth stocks that still have big potential, we asked three Motley Fool investors to profile a top growth investment. Read on to see why they identified Codexis (NASDAQ:CDXS), Activision Blizzard (NASDAQ:ATVI), and Control4 Corporation (NASDAQ:CTRL) as top stocks for growth-seeking investors.

  • [By Ethan Ryder]

    Codexis, Inc. (NASDAQ:CDXS) SVP James Lalonde sold 15,000 shares of the stock in a transaction on Tuesday, July 17th. The stock was sold at an average price of $15.40, for a total value of $231,000.00. Following the sale, the senior vice president now owns 202,566 shares in the company, valued at approximately $3,119,516.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Jason Hall, Chuck Saletta, and Maxx Chatsko]

    And while investors shouldn’t count Elon Musk and Tesla out, it’s never wise to put all your hopes — and money — on a single company. We asked three investors who write for The Motley Fool — one of whom is a Tesla shareholder — for alternative ideas — stocks they think could put Tesla’s future returns to shame. They put together compelling arguments for Clean Energy Fuels Corp. (NASDAQ:CLNE), Berkshire Hathaway Inc. (NYSE:BRK-A)(NYSE:BRK-B), and Codexis, Inc. (NASDAQ:CDXS). 

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Codexis (CDXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Codexis (NASDAQ:CDXS) hit a new 52-week high and low during trading on Monday . The company traded as low as $14.45 and last traded at $13.98, with a volume of 520808 shares traded. The stock had previously closed at $13.50.

Top 10 Medical Stocks To Watch For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Pluristem Therapeutics alerts:

    Pluristem Therapeutics Inc. (PSTI) Given Consensus Rating of “Buy” by Analysts (americanbankingnews.com) Head-To-Head Analysis: Pluristem Therapeutics (PSTI) & Amgen (AMGN) (americanbankingnews.com) Pre-Eclampsia Treatment Market Outlook 2025, Global Opportunity & Growth Analysis, Key Players – Alnylam … (menafn.com) Flickering Three Stocks: Golden Star Resources Ltd. (NYSE:GSS), Pluristem Therapeutics Inc. (NASDAQ:PSTI … (thestreetpoint.com) Pluristem Therapeutics Inc. (PSTI) moves -0.72% higher to SMA-50 (nasdaqplace.com)

    Pluristem Therapeutics stock traded up $0.01 during trading hours on Monday, reaching $1.37. The stock had a trading volume of 3,754 shares, compared to its average volume of 201,217. The firm has a market cap of $150.78 million, a PE ratio of -4.28 and a beta of 0.32. Pluristem Therapeutics has a 52 week low of $1.12 and a 52 week high of $2.12.

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Watch For 2019: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Logan Wallace]

    TESARO Inc (NASDAQ:TSRO) Director Lawrence M. Alleva sold 7,142 shares of the firm’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $43.11, for a total transaction of $307,891.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Todd Campbell]

    Tesaro, Inc. (NASDAQ:TSRO) markets a highly successful therapy for ovarian cancer, Zejula, and its plans for the future include winning approval of Zejula’s use alongside another one of its drugs, TSR-042, in non-small cell lung cancer. Will this combination therapy reshape how oncologists treat lung cancer?

  • [By Paul Ausick]

    Tesaro Inc. (NASDAQ: TSRO) traded down more than 10% Wednesday and posted a new 52-week low of $44.51 after closing Tuesday at $49.63. The stock’s 52-week high is $168.92. Volume totaled around 3 million, approaching three times the daily average of around 1.1 million. European banks were hit hard by events in Italy, but Santander had no specific news.

  • [By Cory Renauer]

    All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others. 

    Company (Symbol) One-Month Loss  Market Capitalization
    Idera Pharmaceuticals (NASDAQ:IDRA) (35%) $199.7 million
    Spark Therapeutics (NASDAQ:ONCE) (38%) $2.16 billion
    Tesaro (NASDAQ:TSRO) (40%) $1.49 billion

    Here’s what needs to happen if these stocks are going to mount a comeback.

  • [By Ethan Ryder]

    TESARO (NASDAQ:TSRO)‘s stock had its “hold” rating reissued by stock analysts at Jefferies Financial Group in a report issued on Friday. They presently have a $38.00 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s price objective indicates a potential upside of 7.71% from the company’s current price.

Top 10 Medical Stocks To Watch For 2019: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Quality Systems (QSII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Quality Systems, Inc. (NASDAQ:QSII) by 493.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 82,275 shares of the company’s stock after purchasing an additional 68,400 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.13% of Quality Systems worth $1,604,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Quality Systems (QSII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of Quality Systems, Inc. (NASDAQ: QSII) got a boost, shooting up 14 percent to $17.08 after the company posted better-than-expected FQ4 results.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

Top 10 Medical Stocks To Watch For 2019: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 10 Medical Stocks To Watch For 2019: HMS Holdings Corp(HMSY)

Advisors’ Opinion:

  • [By Max Byerly]

    Stock analysts at Chardan Capital initiated coverage on shares of HMS (NASDAQ:HMSY) in a report issued on Thursday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $35.00 price target on the business services provider’s stock. Chardan Capital’s price target would indicate a potential upside of 3.67% from the stock’s current price.

  • [By Logan Wallace]

    HMS Holdings Corp (NASDAQ:HMSY) has earned an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $30.13.

  • [By Shane Hupp]

    HMS Holdings Corp (NASDAQ:HMSY) has earned a consensus rating of “Buy” from the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $22.86.

  • [By Logan Wallace]

    Massachusetts Financial Services Co. MA increased its position in shares of HMS Holdings (NASDAQ:HMSY) by 40.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,007,174 shares of the business services provider’s stock after purchasing an additional 292,456 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.21% of HMS worth $16,961,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Macquarie Group Ltd. raised its stake in shares of HMS Holdings Corp (NASDAQ:HMSY) by 344.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the business services provider’s stock after buying an additional 6,200 shares during the period. Macquarie Group Ltd.’s holdings in HMS were worth $173,000 as of its most recent SEC filing.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
    Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
    Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
    California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
    Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
    Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
    Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
    Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
    Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
    Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
    Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result

Top 10 Medical Stocks To Watch For 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to

Top Clean Energy Stocks To Watch For 2019

Clean energy is going to make savvy investors rich, as the global solar power market will skyrocket from $86 billion in 2015 to $422 billion in 2022.

That’s a 390% climb in just seven years.

And fortunately, it’s not too late to join the party.

Thanks to our proprietary stock evaluation system, we’ve uncovered the best solar stock to play this $420 billion solar energy revolution…

Vivint Solar Inc. (NYSE: VSLR) has been one of the most talked-about solar stocks on the market since its IPO on Oct. 1, 2014.

Top Clean Energy Stocks To Watch For 2019: MarineMax, Inc.(HZO)

Advisors’ Opinion:

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.70 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Max Byerly]

    MarineMax, Inc. (NYSE:HZO) EVP Charles A. Cashman sold 25,000 shares of the business’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $22.92, for a total value of $573,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.75 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

Top Clean Energy Stocks To Watch For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top Clean Energy Stocks To Watch For 2019: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Max Byerly]

    SEI Investments (NASDAQ: SEIC) and Investment Technology Group (NYSE:ITG) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

  • [By Joseph Griffin]

    Investment Technology Group (NYSE:ITG) announced a quarterly dividend on Thursday, May 17th, RTT News reports. Investors of record on Wednesday, May 30th will be given a dividend of 0.07 per share by the financial services provider on Friday, June 15th. This represents a $0.28 dividend on an annualized basis and a yield of 1.23%.

Top Clean Energy Stocks To Watch For 2019: Argo Group International Holdings Ltd.(AGII)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Argo Group (NASDAQ: AGII) and Stewart Information Services (NYSE:STC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Joseph Griffin]

    Barclays PLC raised its stake in Argo Group (NASDAQ:AGII) by 25.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,691 shares of the insurance provider’s stock after acquiring an additional 1,754 shares during the period. Barclays PLC’s holdings in Argo Group were worth $499,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Lord Abbett & CO. LLC purchased a new position in shares of Argo Group (NASDAQ:AGII) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 840,251 shares of the insurance provider’s stock, valued at approximately $48,230,000. Lord Abbett & CO. LLC owned approximately 2.49% of Argo Group as of its most recent filing with the SEC.

Top Clean Energy Stocks To Watch For 2019: Abengoa Yield plc(ABY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ArtByte (ABY) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on May 1st, 2014. ArtByte’s total supply is 792,537,250 coins. ArtByte’s official website is www.artbyte.me. ArtByte’s official Twitter account is @artbyteme and its Facebook page is accessible here. The Reddit community for ArtByte is /r/ArtByte and the currency’s Github account can be viewed here.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded down 8% against the dollar during the 1 day period ending at 17:00 PM Eastern on September 6th. During the last week, ArtByte has traded 11.3% higher against the dollar. One ArtByte coin can currently be purchased for about $0.0029 or 0.00000045 BTC on popular cryptocurrency exchanges including LiteBit.eu, Bittrex and Cryptopia. ArtByte has a total market cap of $2.31 million and approximately $4,225.00 worth of ArtByte was traded on exchanges in the last day.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded up 10.8% against the dollar during the 1-day period ending at 20:00 PM ET on June 14th. ArtByte has a market capitalization of $3.84 million and approximately $13,004.00 worth of ArtByte was traded on exchanges in the last 24 hours. One ArtByte coin can currently be purchased for $0.0048 or 0.00000073 BTC on popular cryptocurrency exchanges including Bittrex, Cryptopia and LiteBit.eu. Over the last week, ArtByte has traded 16.9% lower against the dollar.

Top Clean Energy Stocks To Watch For 2019: Schweitzer-Mauduit International Inc.(SWM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Schweitzer-Mauduit International (SWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Swarm (CURRENCY:SWM) traded 9% lower against the U.S. dollar during the 24-hour period ending at 22:00 PM ET on September 5th. In the last seven days, Swarm has traded 9.7% lower against the U.S. dollar. Swarm has a total market capitalization of $6.73 million and approximately $16,882.00 worth of Swarm was traded on exchanges in the last day. One Swarm token can currently be bought for $0.13 or 0.00002047 BTC on major exchanges including Bancor Network, HitBTC, YoBit and IDEX.

  • [By Max Byerly]

    Schweitzer-Mauduit International, Inc. (NYSE:SWM) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $34.66 and last traded at $35.16, with a volume of 1298 shares traded. The stock had previously closed at $35.05.